Rewalk Robotics Ltd (NASDAQ:RWLK) saw a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 2,267,279 shares, a drop of 49.2% from the February 15th total of 4,467,308 shares. Currently, 3.9% of the company’s shares are sold short. Based on an average trading volume of 5,949,919 shares, the days-to-cover ratio is presently 0.4 days.

RWLK stock opened at $0.24 on Friday. The company has a quick ratio of 2.04, a current ratio of 2.46 and a debt-to-equity ratio of 3.59. The firm has a market cap of $16.64 million, a price-to-earnings ratio of -0.41 and a beta of 1.79. Rewalk Robotics has a 52-week low of $0.16 and a 52-week high of $1.35.

Rewalk Robotics (NASDAQ:RWLK) last posted its earnings results on Friday, February 8th. The medical device company reported ($0.10) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.04. The company had revenue of $1.58 million during the quarter. Rewalk Robotics had a negative return on equity of 3,654.32% and a negative net margin of 331.18%.

A hedge fund recently bought a new stake in Rewalk Robotics stock. Geode Capital Management LLC bought a new position in shares of Rewalk Robotics Ltd (NASDAQ:RWLK) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 284,311 shares of the medical device company’s stock, valued at approximately $49,000. Geode Capital Management LLC owned about 0.39% of Rewalk Robotics as of its most recent SEC filing. 6.51% of the stock is owned by institutional investors.

Separately, ValuEngine raised Rewalk Robotics from a “hold” rating to a “buy” rating in a research note on Monday, February 4th.

ILLEGAL ACTIVITY WARNING: This story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at

About Rewalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Read More: The risks of owning bonds

Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with's FREE daily email newsletter.